Opioid prescribing for acute postoperative pain after cutaneous surgery - 11/02/19
Abstract |
Background |
Little information is available to predict which patients require opioid analgesia following cutaneous surgery. When opioids are indicated, information regarding the optimal opioid agent selection and dosage is lacking.
Objective |
To make recommendations for opioid prescription after cutaneous surgery.
Methods |
A PubMed literature search was conducted to review the available literature. Recommendations are presented on the basis of available evidence and the opinion of the authors.
Results |
Most patients undergoing cutaneous surgery do not require opioid analgesia. For those who do, the duration of pain warranting opioid analgesia is generally less than 36 hours. Opioid refill requests warrant a follow-up visit to ascertain the cause of ongoing pain after excisional procedures.
Limitations |
The recommendations are not based on prospective randomized trials.
Conclusions |
The presented recommendations for opioid prescription practice are derived from available evidence, recommendations, and expert opinion.
Le texte complet de cet article est disponible en PDF.Key words : addiction, cutaneous surgery, dermatologic surgery, flap, Mohs micrographic surgery, narcotic, opioid, pain, public health
Plan
| Funding sources: None. |
|
| Conflict of interests: None disclosed. |
Vol 80 - N° 3
P. 743-748 - mars 2019 Retour au numéro
Article précédent
- Topical use of mammalian target of rapamycin inhibitors in dermatology: A systematic review with meta-analysis
- Sophie Leducq, Bruno Giraudeau, Elsa Tavernier, Annabel Maruani
- Clear cell acanthoma (CCA)-like lesions of the nipple/areola: A clinicopathological study of 12 cases supporting a nonneoplastic eczematous disease
- Kang-Ling Kuo, Chi-Shou Lo, Li-yu Lee, Chih-Hsun Yang, Tseng-tong Kuo
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?